Elda Fischi GomezElda Fischi-Gomez holds a BsC and a MsC degree in Telecommunication Engineering from the Polytechnic University of Catalonia (UPC, Barcelona, Spain) and a PhD in Electrical Engineering from the Swiss Federal Institute of Technology (EPFL, Lausanne, Switzerland, 2015). Her main research interests center on the development and application of novel MRI techniques to clinics by optimising the inter-play between multi-modal MR analysis, MR physic/hardware and the underlying clinical neuroscience. She has worked as a post-doctoral fellow at the A.A. Martinos Center of Biomedical Imaging of the Massachusetts General Hospital, Harvard Medical School (Boston, MA, USA) with a Swiss National Foundation Fellowship. Since 2019 she joined the Signal Processing Laboratory 5 of the Swiss Federal Institute of Technology Lausanne (EPFL) with a SPN-PHRT individual grant from the EPFL-ETH domain on microstructure imaging for multiple sclerosis.
Maria Giulia PretiMaria Giulia Preti received her Ph.D. in Bioengineering at Politecnico di Milano (Milan, Italy) in 2013, after her M. Sc. (2009) and B. Sc. (2007) in Biomedical Engineering, as well at Politecnico di Milano. During her Ph.D., mentored by Prof. Giuseppe Baselli, she focused on advanced techniques of brain magnetic resonance imaging, in particular she developed a method of groupwise fMRI-guided tractography, that revealed to be useful in the in-vivo investigation of the pathophysiological changes across the evolution of Alzheimers disease. For this project, she had been collaborating full-time with the hospital Fondazione Don Gnocchi in Milan (Magnetic Resonance Laboratory). In 2011, she was awarded a Progetto Rocca fellowship from MIT-Italy and spent a visiting research period at the MIT and Harvard Medical School (Boston, USA), under the supervision of Prof. Nikos Makris, where she could focus on the anatomical study of specific neruonal bundles.
She has joined Prof. Van De Ville group at EPFL as a post-doc in 2013. Her current research aims at understanding the connections between brain functionality and brain microscopic anatomy by using advanced techniques of Magnetic Resonance Imaging. In particular, she is working on functional MRI, functional connectivity, diffusion tensor imaging and tractography, integration of MRI with other techniques (e.g. EEG), and the application of these methods to several clinical contexts, e.g., epilepsy, Alzheimer's disease and mild cognitive impairment, multiple sclerosis, attention deficit hyperactivity disorder.
Patrick AebischerPatrick Aebischer a achevé une formation en Médecine (1980) et en Neurosciences (1983) aux Universités de Genève et de Fribourg en Suisse.
De 1984 à 1992, Patrick Aebischer a travaillé à Brown University (USA) au sein du Département des Neurosciences et au Département des Biomatériaux et des Organes Artificiels en tant que Professeur assistant, puis Professeur associé.
En 1992, Patrick Aebischer a été nommé Professeur de la Division Autonome de Recherche Chirurgicale et du Centre de Thérapie Génique (DARC) au Centre Hospitalier Universitaire Vaudois (CHUV) à Lausanne.
En 1999, Le Conseil Fédéral a nommé Patrick Aebischer en tant que Président de l'Ecole Polytechnique Fédérale de Lausanne (EPFL). Il a pris ses fonctions à la Présidence de lEPFL en mars 2000, position qu'il a occupée jusqu'au 31 décembre 2016.
Patrick Aebischer est membre de maintes sociétés professionnelles, tant en Europe quaux Etats-Unis.
Patrick Aebischer a fondé trois start-up de biotechnologies. Il siège au conseil d'administration de Lonza, de Logitech et de Nestlé. Il préside également l'advisory board du Novartis Venture Fund. Patrick Aebischer est membre du conseil de fondation du Festival de Jazz de Montreux, du Festival de Verbier et de la Fondation Jacobs.
Les recherches quil poursuit actuellement dans son laboratoire se concentrent sur le développement d'approches de thérapie cellulaire et de transfert génique pour le traitement des maladies neurodégénératives.
Lijing XinLijing Xin is a research staff scientist and 7T MR Operational Manager at the Center for Biomedical Imaging (CIBM), Ecole polytechnique fédérale de Lausanne (EPFL), Switzerland. Her research interests focus on developing cutting-edge magnetic resonance spectroscopy and imaging methods for better understanding the brain function and the pathophysiology of neurological diseases. Her journey on magnetic resonance imaging (MRI) started from her master project during 2002-2005, where she developed a gradient unit with eddy current compensation and a pulse sequence generator for MRI spectrometer, which enhanced her knowledge in MR instrumentation. Later, she obtained her PhD in physics from Ecole polytechnique fédérale de Lausanne (EPFL) in 2010, where she focused on developing various novel 1H and 13C magnetic resonance spectroscopy (MRS) acquisition and quantification methods as well as RF coils on high field preclinical MR scanners. Afterwards, she started working on the clinical MR platforms including both 3 and 7T and continued to improve and develop novel acquisition and quantification methods for 1H, 13C and 31P nuclei. She carries on interdisciplinary collaborations with different partners, particularly with clinical partners where translational strategies are performed to explore the pathophysiology of psychiatric disorders and disease biomarkers for early diagnose and intervention.
